![Jeff Boyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Boyle
Investor Relations Kontakt på
ARVINAS, INC.
Profil
Jeff Boyle is Vice President-Investor Relations at Arvinas, Inc. since 2021.
Formerly, Mr. Boyle was Vice President-Investor Relations at SAGE Therapeutics, Inc. from 2017 to 2021 and Senior Director-Corporate & Investor Relations at DNIB Unwind, Inc. from 2014 to 2016.
Education includes undergraduate studies at The University of Colorado.
Aktiva positioner av Jeff Boyle
| Företag | Position | Start |
|---|---|---|
| ARVINAS, INC. | Investor Relations Kontakt | 2021-09-01 |
Tidigare kända positioner av Jeff Boyle
| Företag | Position | Slut |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Investor Relations Kontakt | 2021-09-01 |
| DNIB UNWIND INC | Investor Relations Kontakt | 2016-11-30 |
Jeff Boyles utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
57
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
